{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:01:14Z","timestamp":1782831674823,"version":"3.54.5"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 111-2314-B-075-040-MY2"],"award-info":[{"award-number":["MOST 111-2314-B-075-040-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jfma.2023.08.010","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T07:53:19Z","timestamp":1692690799000},"page":"S141-S152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S2","title":["Follow-up care and assessment of comorbidities and complications in patients with primary aldosteronism: The clinical practice guideline of the Taiwan Society of aldosteronism"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2983-3686","authenticated-orcid":false,"given":"Li-Hsin","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7864-8793","authenticated-orcid":false,"given":"Ying-Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Ting","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7692-3106","authenticated-orcid":false,"given":"Chih-Yao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Shin","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-1541","authenticated-orcid":false,"given":"I-Weng","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Kai","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-790X","authenticated-orcid":false,"given":"Liang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2023.08.010_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/M20-0065","article-title":"The unrecognized prevalence of primary aldosteronism: a cross-sectional study","volume":"173","author":"Brown","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jfma.2023.08.010_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/HYPERTENSIONAHA.119.14359","article-title":"Screening rates for primary aldosteronism in resistant hypertension: a cohort study","volume":"75","author":"Jaffe","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib3","article-title":"Cerebro-cardiovascular risk, target organ damage, and treatment outcomes in primary aldosteronism","volume":"8","author":"Lin","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jfma.2023.08.010_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.010_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib7","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib8","first-page":"225","article-title":"2022 Guidelines of the Taiwan society of Cardiology and the Taiwan hypertension society for the management of hypertension","volume":"38","author":"Wang","year":"2022","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jfma.2023.08.010_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jfma.2018.01.006","article-title":"Targeted treatment of primary aldosteronism - the consensus of Taiwan Society of Aldosteronism","volume":"118","author":"Huang","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.08.010_bib10","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jfma.2017.06.004","article-title":"Case detection and diagnosis of primary aldosteronism - the consensus of Taiwan Society of Aldosteronism","volume":"116","author":"Wu","year":"2017","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2023.08.010_bib11","first-page":"213","article-title":"The 2017 focused update of the guidelines of the Taiwan society of Cardiology (TSOC) and the Taiwan hypertension society (THS) for the management of hypertension","volume":"33","author":"Chiang","year":"2017","journal-title":"Acta Cardiol Sin"},{"key":"10.1016\/j.jfma.2023.08.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcma.2014.11.005","article-title":"2015 Guidelines of the Taiwan society of Cardiology and the Taiwan hypertension society for the management of hypertension","volume":"78","author":"Chiang","year":"2015","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jfma.2023.08.010_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ncpneph0151","article-title":"Primary aldosteronism: diagnostic and treatment strategies","volume":"2","author":"Mattsson","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.jfma.2023.08.010_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s002689900552","article-title":"Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production","volume":"22","author":"Rutherford","year":"1998","journal-title":"World J Surg"},{"key":"10.1016\/j.jfma.2023.08.010_bib15","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2014-1153","article-title":"Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study","volume":"99","author":"Ahmed","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.010_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.jfma.2023.08.010_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.010_bib19","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jfma.2023.08.010_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1507\/endocrj.K10E-402","article-title":"Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome","volume":"58","author":"Hiraishi","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.jfma.2023.08.010_bib21","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1210\/jc.2010-2743","article-title":"Cardiovascular complications of patients with aldosteronism associated with autonomous cortisol secretion","volume":"96","author":"Nakajima","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib22","article-title":"Clinical characteristics of aldosterone- and cortisol-coproducing adrenal adenoma in primary aldosteronism","volume":"2018","author":"Tang","year":"2018","journal-title":"Internet J Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.010_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s42000-019-00114-8","article-title":"The relevance of cortisol co-secretion from aldosterone-producing adenomas","volume":"18","author":"Bhatt","year":"2019","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.jfma.2023.08.010_bib24","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1210\/jc.2019-00299","article-title":"Impaired glucose metabolism in primary aldosteronism is associated with cortisol cosecretion","volume":"104","author":"Gerards","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib25","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2023.08.010_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/a-1164-1944","article-title":"The impact of glucocorticoid Co-secretion in primary aldosteronism on thyroid autoantibody titers during the course of disease","volume":"52","author":"Handgriff","year":"2020","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2023.08.010_bib27","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.645488","article-title":"Cortisol Co-secretion and clinical usefulness of ACTH stimulation test in primary aldosteronism: a systematic review and biases in epidemiological studies","volume":"12","author":"Inoue","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfma.2023.08.010_bib29","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European society of Endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jfma.2023.08.010_bib30","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/jc.2014-1401","article-title":"Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature","volume":"99","author":"Di Dalmazi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/SLE.0000000000000585","article-title":"Is prophylactic steroid treatment mandatory for subclinical cushing syndrome after unilateral laparoscopic adrenalectomy?","volume":"29","author":"Wang","year":"2019","journal-title":"Surg Laparosc Endosc Percutaneous Tech"},{"key":"10.1016\/j.jfma.2023.08.010_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jfma.2023.08.010_bib33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2023.08.010_bib34","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1210\/jc.2011-1135","article-title":"Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis","volume":"96","author":"Wu","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1055\/s-0035-1565124","article-title":"Cardiovascular risk in primary hyperaldosteronism","volume":"47","author":"Prejbisz","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2023.08.010_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s11906-009-0076-8","article-title":"Aldosterone and cardiovascular risk","volume":"11","author":"Vogt","year":"2009","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jfma.2023.08.010_bib37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40292-021-00485-3","article-title":"Evaluation of intra-renal stiffness in patients with primary aldosteronism","volume":"29","author":"Petramala","year":"2022","journal-title":"High Blood Pres Cardiovasc Prev"},{"key":"10.1016\/j.jfma.2023.08.010_bib38","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2023.08.010_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality\u00a0in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2023.08.010_bib40","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1172\/JCI118867","article-title":"Role of aldosterone in the remnant kidney model in the rat","volume":"98","author":"Greene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jfma.2023.08.010_bib41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","article-title":"Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1","volume":"49","author":"Shibata","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/HYPERTENSIONAHA.121.17436","article-title":"Renal injuries in primary aldosteronism: quantitative histopathological analysis of 19 patients with primary adosteronism","volume":"78","author":"Ogata","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib43","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2215\/CJN.00050107","article-title":"Relationships of plasma renin levels with renal function in patients with primary aldosteronism","volume":"2","author":"Catena","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2023.08.010_bib44","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1681\/ASN.2004100878","article-title":"Relative glomerular hyperfiltration in primary aldosteronism","volume":"16","author":"Ribstein","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jfma.2023.08.010_bib45","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1210\/jc.2008-1851","article-title":"Risk factors associated with a low glomerular filtration rate in primary aldosteronism","volume":"94","author":"Reincke","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib46","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cca.2011.02.018","article-title":"Kidney impairment in primary aldosteronism","volume":"412","author":"Wu","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jfma.2023.08.010_bib47","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.2337\/diacare.21.7.1076","article-title":"Proteinuria is still useful for the screening and diagnosis of overt diabetic nephropathy","volume":"21","author":"Zelmanovitz","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2023.08.010_bib48","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension","volume":"21","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.010_bib49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib50","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","article-title":"Long-term renal outcomes in patients with primary aldosteronism","volume":"295","author":"Sechi","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2023.08.010_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.010_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.574151","article-title":"Primary aldosteronism and bone metabolism: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfma.2023.08.010_bib53","article-title":"Bone and mineral metabolism in patients with primary aldosteronism: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfma.2023.08.010_bib54","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/jbmr.1660","article-title":"Bone involvement in aldosteronism","volume":"27","author":"Salcuni","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2023.08.010_bib55","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1210\/jc.2016-3206","article-title":"Primary aldosteronism as a risk factor for vertebral fracture","volume":"102","author":"Notsu","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib56","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1210\/jc.2017-02043","article-title":"Lower trabecular bone score in patients with primary aldosteronism: human skeletal deterioration by aldosterone excess","volume":"103","author":"Kim","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jbmr.3033","article-title":"Risk of fracture in primary aldosteronism: a population-based cohort study","volume":"32","author":"Wu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2023.08.010_bib58","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.steroids.2014.08.016","article-title":"Effects of aldosterone on insulin sensitivity and secretion","volume":"91","author":"Luther","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.jfma.2023.08.010_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.870047","article-title":"Differences in glycemic abnormalities between primary aldosteronism and essential hypertension: a systematic review and meta-analysis","volume":"13","author":"Manosroi","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfma.2023.08.010_bib60","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/HJH.0000000000001361","article-title":"Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years","volume":"35","author":"Wu","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/j.jfma.2023.08.010_bib61","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jfma.2023.08.010_bib62","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.2337\/dc12-0607","article-title":"Expansion of the homeostasis model assessment of beta-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2","volume":"36","author":"Hill","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2023.08.010_bib63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1210\/jc.2002-030024","article-title":"Comparison of the insulin action parameters from hyperinsulinemic clamps with homeostasis model assessment and QUICKI indexes in subjects with different endocrine disorders","volume":"89","author":"Skrha","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib64","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","article-title":"Elevated prevalence of abnormal glucose metabolism in patients with primary\u00a0aldosteronism: a meta-analysis","volume":"183","author":"Chen","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.jfma.2023.08.010_bib65","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1210\/jc.2006-0736","article-title":"Insulin sensitivity in patients with primary aldosteronism: a follow-up study","volume":"91","author":"Catena","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib66","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2023.08.010_bib68","article-title":"Cardiovascular risk in primary aldosteronism: a systematic review and meta-analysis","volume":"98","author":"Wu","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jfma.2023.08.010_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fendo.2020.00121","article-title":"Long-term mortality for patients of primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"11","author":"Meng","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jfma.2023.08.010_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/jdi.13332","article-title":"Impact of primary aldosteronism on renal function in patients with type 2 diabetes","volume":"12","author":"Katsuragawa","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.jfma.2023.08.010_bib71","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jfma.2023.08.010_bib72","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jfma.2023.08.010_bib73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623003248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623003248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:51:40Z","timestamp":1760539900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623003248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":73,"alternative-id":["S0929664623003248"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.08.010","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Follow-up care and assessment of comorbidities and complications in patients with primary aldosteronism: The clinical practice guideline of the Taiwan Society of aldosteronism","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}